Pharmafile Logo
Pharmafocus logo
Advanced Search
8655563196_1c0f83c447_z

United Therapeutics buys Arena’s hypertension drug ralinepag in deal worth $1.2 billion

November 16, 2018
Medical Communications Arena, PAH, United Therapeutics, deal sales, hypertension

US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a …

News
ipsen-logo-big

Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma

November 16, 2018
Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission

Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …

News
2tec9don_400x400

Dermavant appoint Todd Zavodnick as CEO

November 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …

Appointment
psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …

Feature

Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund

November 15, 2018
Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma

NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …

News
merckentranceweb

MSD’s Keytruda improvess overall survival in Phase 3 oesophageal cancer

November 15, 2018
Research and Development Cancer, MSD, PD-L1, keytruda, pharma

MSD has announced new Phase 3 data on its anti-PD-1 therapy Keytruda (pembrolizumab) as a second-line treatment for advanced or …

News
4768764591_9e4f7f0eb8_z

Phamaceutical trade lobby responds to Brexit deal

November 15, 2018
Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics

The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …

News

Pfizer defeated in Britain’s highest court over Lyrica patent

November 15, 2018
Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma

American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …

News
novartis_outside_1

Novartis denies potential split with Sandoz

November 15, 2018
Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers

Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …

News

Company tackling antimicrobial resistance appoint former Bayer VP as new managing director

November 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …

Appointment
diabetes-777001_960_720

3 in 4 UK diabetes patients suffer from mental health issues, says report

November 14, 2018
Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma

To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …

News
310px-pharmacie_in_paulista_avenue

German health minister Jens Spahn calls for faster adoption of biosimilars

November 14, 2018
Research and Development AbbVie, Germany, biosimilars, jens Spahn

Germany’s health minister Jens Spahn has called for faster uptake of biosimilars in an effort to cut the cost of …

News
20441424453_40a90aa0b3_k

Ebola outbreak in Congo may last another 6 months, WHO officials say

November 14, 2018
Research and Development Congo, Ebola, WHO, health, infectious diseases

The outbreak of Ebola in the Democratic Republic of Congo (DRC) is expected to last until mid-2019, a World Health …

News

WHO report reveals antibiotic use by country

November 14, 2018
Research and Development

Britain uses more than twice as many antibiotics as the Netherlands, according to a new report published by the World …

News
samsung_bioepis

Samsung BioLogics delisted over accounting violations

November 14, 2018
Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …

News
novartis_window

Novartis’ Entresto tops enalapril in stabilised heart failure patients

November 13, 2018
Manufacturing and Production, Research and Development Entresto, Novartis, cardiovascular, enalapril, heart failure, pharma

Novartis has declared new findings for Entresto (sacubitril/valsartan) at the American Heart Association’s (AHA) scientific sessions, showing that the drug proved …

News
michael_boyd

Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs

November 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …

Appointment

Cases of measles nearly quadruple since last year in UK

November 13, 2018
Manufacturing and Production MMR, Public Health England, UK, health, measles

Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after …

News
acute_lymphoblastic_leukaemia_smear

Azacitidine and nivolumab combo proves successful in phase II trial

November 13, 2018
Manufacturing and Production Cancer, leukaemia, opdivo, pharma, texas

A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with relapsed or …

News
shutterstock_273326141

AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn

November 13, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi

AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026